Details for New Drug Application (NDA): 204213
✉ Email this page to a colleague
The generic ingredient in FYAVOLV is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.
Summary for 204213
Tradename: | FYAVOLV |
Applicant: | Lupin Ltd |
Ingredient: | ethinyl estradiol; norethindrone acetate |
Patents: | 0 |
Pharmacology for NDA: 204213
Mechanism of Action | Estrogen Receptor Agonists |
Suppliers and Packaging for NDA: 204213
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
FYAVOLV | ethinyl estradiol; norethindrone acetate | TABLET;ORAL | 204213 | ANDA | Lupin Pharmaceuticals, Inc. | 68180-827 | 68180-827-09 | 90 TABLET, FILM COATED in 1 BOTTLE (68180-827-09) |
FYAVOLV | ethinyl estradiol; norethindrone acetate | TABLET;ORAL | 204213 | ANDA | Lupin Pharmaceuticals, Inc. | 68180-827 | 68180-827-73 | 3 POUCH in 1 CARTON (68180-827-73) / 1 BLISTER PACK in 1 POUCH / 28 TABLET, FILM COATED in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 0.0025MG;0.5MG | ||||
Approval Date: | Dec 10, 2015 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 0.005MG;1MG | ||||
Approval Date: | Dec 10, 2015 | TE: | AB | RLD: | No |
Complete Access Available with Subscription